Hints and tips:
Related Special Reports
...This primes the body to recognise the virus if infected and make an immune response....
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
...Anyway, if you want to commemorate Risher et. al’s gaffe, boy oh boy do we have the t-shirt/sticker for you over on the FTAV swag shop (wow two promos in one day). It’ll look great under your gilet....
...Of course, O’Neill et al were mostly talking about these countries as burgeoning economies with tons of potential. And many of these countries have indeed subsequently done well....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...Productivity-hype bubbles are usually separated by at least 25 years and usually form at the end of a secular bull market, when aggregate profits are coming under pressure, say Garthwaite et al....
...Teresa Graham, chief of Roche’s pharmaceutical division, said more patients suffered from diseases of the immune system than from cancer, and the current drugs did not serve them well....
...Last month, NWBO and its Reddit fans were rebuffed by a Manhattan court, which granted Citadel et al’s motion to dismiss the case. But there was a sting in the tail....
...Pfizer spent $6.7bn on Arena Pharmaceuticals in December, lured by its medicines for immune-inflammatory diseases, and paid $2.3bn in August last year for Trillium Therapeutics as it targeted treatments...
...They followed the Pinault family of Ch Latour et al, who, in 2013, bought what is now called The Eisele Vineyard from the Araujos, and were so confident of their savoir-faire that they didn’t even impose...
...MSD helped transform cancer care with its drug Keytruda, which harnessed the immune system to tackle tumours....
...Antiviral medicines target viruses in a bid to prevent them infecting healthy cells, helping immune systems fight off the infection....
...However, Weinstein et al say they are excited to a large extent because those aforementioned risks are now materialising. As private credit investors, this is the environment we’ve been waiting for....
...The all-cash transaction for Prometheus — a San Diego-based biotech focusing on diseases caused by abnormal activity of the body’s immune system — is the latest sign of a rebound in mergers and acquisitions...
...CC Pakistan et al....
...say Jonas et al. Yes it can! Look! And look! And look! That’s Tesla on an EV of 28.3 times 2025 ebitda, per Morgan Stanley forecasts, which is more expensive than Nvidia’s 25.3 times ebitda....
...Was this the year where Weiner et al. finally opened their eyes to the delights of boneless chicken, Domino’s pasta and sandwiches, or even the occasional salad?...
...Here’s Citi’s Andrew Coombs et al. then: For the European banks, we see less risk of deposit flight and believe they have more liquid balance sheets....
...Bauman said the vaccine stimulated a person’s immune system to selectively target those cancer cells....
...Alexion specialises in “complement biology”, creating drugs that control this important part of the immune system when it overreacts and causes diseases that can damage tissues....
...Investors are betting that Eisai, a $20bn pharmaceutical company still little known outside of Japan, can succeed where many larger companies have failed....
...Nor are these “breakthrough” infections necessarily as mild as many people believe, said Ziyad Al-Aly, a clinical epidemiologist at Washington University in St Louis....
...Pfizer said the 60 microgram dose produced an immune response that was three times higher than the existing BioNTech/Pfizer vaccine....
...Moderna on Friday said it will sue Pfizer and BioNTech for copying the “groundbreaking technology” behind its Covid-19 vaccine, setting up a legal clash between pharmaceutical rivals behind some of the best-selling...
...The US company’s drug tofersen targets a defective gene called SOD1, which causes about 2 per cent of cases of MND, also known as amyotrophic lateral sclerosis or ALS in North America....
International Edition